scRNA-seq reveals an immune microenvironment and JUN-mediated NK cell exhaustion in relapsed T-ALL.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40306275.
- Also identified by DOI 10.1016/j.xcrm.2025.102098 and PMC identifier 12147915.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
T cell acute lymphoblastic leukemia (T-ALL) is a heterogeneous disease characterized by a high relapse rate. By single-cell transcriptome analysis, we characterize the bone marrow immune microenvironment in patients with T-ALL, identifying 13 major cell clusters. These patients exhibited abnormally expanded hematopoietic stem cells (HSCs) and granulocyte-monocyte progenitors (GMPs), immunosuppressive traits in CD4<sup>+</sup> T, CD8<sup>+</sup> T, and natural killer (NK) cells. Subdividing CD4<sup>+</sup> T cells reveal two subsets transitioning between T helper (Th)1/Th2, Annexin-A1 (ANXA1)<sup>-</sup>GATA3<sup>-</sup>CD4<sup>+</sup> T, and ANXA1<sup>+</sup>GATA3<sup>+</sup>CD4<sup>+</sup> T. Additionally, NK cells demonstrate exhaustion in the tumor microenvironment of patients with relapsed T-ALL, with JUN identified as a critical factor. Additionally, JUN is also highly expressed in T-ALL and is crucial for maintaining its proliferation. The JUN inhibitor exhibited successful lethality toward leukemia cells and ameliorated NK cell exhaustion in relapsed T-ALL cell line, as well as in cell-derived tumor xenograft (CDX), patient-derived tumor xenograft (PDX), and NOTCH1-mutant mouse models. In summary, our findings enhance the understanding of T-ALL relapse mechanisms and support the development of innovative immunotherapies for patients with relapsed T-ALL.
Medical subject headings
- Killer Cells, Natural
- Tumor Microenvironment
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
- RNA-Seq